Location History:
- Ridgewood, NJ (US) (2001)
- Tarrytown, NY (US) (2010)
Company Filing History:
Years Active: 2001-2010
Title: The Innovative Contributions of Jolanta Kunicka
Introduction
Jolanta Kunicka is a prominent inventor based in Tarrytown, NY (US). She has made significant contributions to the field of medical diagnostics, particularly in the analysis of blood and body fluid samples. With a total of 3 patents to her name, her work has advanced the methodologies used in clinical laboratories.
Latest Patents
One of her latest patents is focused on a reagent composition for the analysis of residual white blood cells in leuko-reduced blood banking products. This invention allows for the enumeration and analysis of residual white blood cells by forming a suspension of leukocyte-reduced blood products with a lysing reagent. The reagent is designed to selectively lyse platelets and red blood cells without damaging the white blood cells, ensuring accurate measurement of the stained white blood cells. Another notable patent involves an automated method and reagent for assaying body fluid samples, such as cerebrospinal fluid (CSF). This invention describes semi- and fully-automated methods that provide detailed analysis, including red blood cell and white blood cell counts, as well as differential values.
Career Highlights
Throughout her career, Jolanta has worked with leading companies in the healthcare sector, including Siemens Healthcare Diagnostics GmbH and Bayer Corporation. Her expertise in medical diagnostics has positioned her as a valuable asset in the development of innovative solutions for clinical analysis.
Collaborations
Jolanta has collaborated with several professionals in her field, including Gena Fischer and David Zelmanovic. These partnerships have contributed to the successful development and implementation of her patented technologies.
Conclusion
Jolanta Kunicka's contributions to medical diagnostics through her innovative patents demonstrate her commitment to improving healthcare solutions. Her work continues to influence the field and enhance the accuracy of clinical analyses.